WO2016112191A1 - Augmentations pour déficits osseux - Google Patents

Augmentations pour déficits osseux Download PDF

Info

Publication number
WO2016112191A1
WO2016112191A1 PCT/US2016/012491 US2016012491W WO2016112191A1 WO 2016112191 A1 WO2016112191 A1 WO 2016112191A1 US 2016012491 W US2016012491 W US 2016012491W WO 2016112191 A1 WO2016112191 A1 WO 2016112191A1
Authority
WO
WIPO (PCT)
Prior art keywords
augment
bone
individual
implant
defect
Prior art date
Application number
PCT/US2016/012491
Other languages
English (en)
Inventor
Stulberg Bernard
Anglbaud Laurent
Alvarez Luis
Doyle Jim
Original Assignee
Exactech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exactech, Inc. filed Critical Exactech, Inc.
Priority to US15/554,189 priority Critical patent/US20180049878A1/en
Publication of WO2016112191A1 publication Critical patent/WO2016112191A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30721—Accessories
    • A61F2/30734—Modular inserts, sleeves or augments, e.g. placed on proximal part of stem for fixation purposes or wedges for bridging a bone defect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/38—Joints for elbows or knees
    • A61F2/389—Tibial components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A61F2002/2835—Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006—Properties of materials and coating materials
    • A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30721—Accessories
    • A61F2/30734—Modular inserts, sleeves or augments, e.g. placed on proximal part of stem for fixation purposes or wedges for bridging a bone defect
    • A61F2002/30736—Augments or augmentation pieces, e.g. wedges or blocks for bridging a bone defect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30772—Apertures or holes, e.g. of circular cross section
    • A61F2002/30784—Plurality of holes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30841—Sharp anchoring protrusions for impaction into the bone, e.g. sharp pins, spikes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30878—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30878—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
    • A61F2002/30879—Ribs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/3092—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/38—Joints for elbows or knees
    • A61F2002/3895—Joints for elbows or knees unicompartimental

Definitions

  • the present invention relates to augments for bone deficiencies and a procedure for implanting these augments.
  • the augments of the present invention when implanted in the body, are sufficiently designed to replace joint stability and function to the extent possible, and to restore deficient bone to enhance that ability.
  • Implantation of joint-replacement prostheses sometimes requires compensation for bone loss.
  • peripheral defects in the proximal tibia can be difficult to treat during total knee arthroplasty.
  • attempts can be made to solve the problem with cement, cement with screws, bone grafts, metal wedges, metal cones, metal sleeves and custom components.
  • These "augments" provide support to the main implant, fashion a specific custom implant for a particular patient's deficiencies, or provide a technique of removing bone to a predictable shape, that allows some standardization of the augments and the technique for implanting them.
  • Augments allow positioning of joint implants in a kinematically appropriate manner.
  • Remaining deficiencies or gaps are filled either with bone graft, bone cement or both.
  • the metal augments are initially attached directly to the implant, using a number of modes of attachment, including screws, snap-fit mating geometry and bone cement, and then the composite (augment/implant) is attached to bone either directly or with bone cement.
  • the present invention relates to augments for bone deficiencies and a procedure for implanting these augments.
  • the augments of the present invention when implanted in the body, are sufficiently designed to replace joint stability and function to the extent possible, and to restore deficient bone to enhance that ability.
  • an augment includes a first side (sufficiently designed to contact a receiving bone), a second side (sufficiently designed to contact an implant), and an exterior profile, wherein the first side and the second side are separated by a thickness, wherein the augment is sufficiently designed for anchoring to the receiving bone at a surface of the bone associated with the void to repair the bone defect.
  • the exterior profile of the augment is defined by a posterior curvature, a lateral curvature, an anterior curvature, and a truncated aspect.
  • the augment is manufactured from a metal biomaterial.
  • the augment is manufactured from a ceramic biomaterial.
  • the augment is manufactured from a composite biomaterial.
  • the augment is manufactured from a polymer biomaterial. In an embodiment, the augment is manufactured from a natural polymer biomaterial. In an embodiment, the augment is manufactured from a synthetic polymer biomaterial. In an embodiment, the augment is manufactured from a combination of a natural and synthetic polymer biomaterial. In an embodiment, a portion of the augment is manufactured from a resorbable biomaterial. In an embodiment, the entire augment is manufactured from a resorbable biomaterial. In an embodiment, the at least one fixation means is selected from the group consisting of pegs, pins, posts, buttons, keels, spikes and hooks.
  • an augment includes a three dimensional endoskeleton support having interconnected macropores providing a framework for host bone to grow into the augment, wherein the support has a first side (sufficiently designed to contact a receiving bone), a second side (sufficiently designed to contact an implant), and an exterior profile, wherein the first side and the second side are separated by a thickness, wherein the support is sufficiently designed for anchoring to the receiving bone at a surface of the bone associated with the void to repair the bone defect.
  • the exterior profile is defined by a posterior curvature, a lateral curvature, an anterior curvature, and a truncated aspect.
  • the support is manufactured from a natural biomaterial.
  • the support is manufactured from a synthetic biomaterial. In an embodiment, the support is manufactured from a combination of a natural and synthetic biomaterial. In an embodiment, a portion of the support is manufactured from a resorbable biomaterial. In an embodiment, the entire support is manufactured from a resorbable biomaterial. In an embodiment, the at least one fixation means is selected from the group consisting of pegs, pins, posts, buttons, keels, spikes and hooks.
  • an augment includes a three dimensional endoskeleton support having interconnected macropores providing a framework for host bone to grow into the augment, wherein the support is manufactured from a microporous biomaterial, wherein the support has a first side, a second side and an exterior profile defined by a posterior curvature, a lateral curvature, an anterior curvature, and a truncated aspect, wherein the first side and the second side are separated by a thickness, wherein the augment is sufficiently designed for anchoring to the receiving bone at a surface of the bone associated with the void to repair the bone defect, and wherein the second side is sufficiently designed to engage a component of an orthopaedic implant.
  • the support is manufactured from a natural biomaterial.
  • the support is manufactured from a synthetic biomaterial. In an embodiment, the support is manufactured from a combination of a natural and synthetic biomaterial. In an embodiment, a portion of the support is manufactured from a resorbable biomaterial. In an embodiment, the entire support is manufactured from a resorbable biomaterial. In an embodiment, the at least one fixation means is selected from the group consisting of pegs, pins, posts, buttons, keels, spikes and hooks.
  • a prosthesis system includes a joint prosthesis component; and an augment comprising a first side (sufficiently designed to contact a receiving bone), a second side (sufficiently designed to contact an implant), and thickness therebetween, wherein the augment is sufficiently designed for anchoring to the receiving bone at a surface of the bone associated with the void to repair the bone defect.
  • the system further includes bone graft material.
  • the augment is manufactured from a metal biomaterial.
  • the augment is manufactured from a ceramic biomaterial.
  • the augment is manufactured from a composite biomaterial.
  • the augment is manufactured from a polymer biomaterial.
  • the augment is manufactured from a natural polymer biomaterial.
  • the augment is manufactured from a synthetic polymer biomaterial. In an embodiment, the augment is manufactured from a combination of a natural and synthetic polymer biomaterial. In an embodiment, a portion of the augment is manufactured from a resorbable biomaterial. In an embodiment, the entire augment is manufactured from a resorbable biomaterial. In an embodiment, the at least one fixation means is selected from the group consisting of pegs, pins, posts, buttons, keels, spikes and hooks.
  • a knee prosthesis system includes a tibial tray component having an inferior surface, a superior surface, and an exterior profile; and an augment comprising a distal side (sufficiently designed to contact a receiving bone), a proximal side (sufficiently designed to contact an implant and an exterior profile, wherein the distal side and the proximal side are separated by a thickness, wherein the augment is sufficiently designed for anchoring to the receiving bone at a surface of the bone associated with the void to repair the bone defect.
  • the exterior profile is defined by a posterior curvature, a lateral curvature, an anterior curvature, and a truncated aspect, at least one of which mimics the exterior profile of the tibial tray component.
  • the system further includes bone graft material.
  • the augment is manufactured from a metal biomaterial.
  • the augment is manufactured from a ceramic biomaterial.
  • the augment is manufactured from a composite biomaterial.
  • the augment is manufactured from a polymer biomaterial.
  • the augment is manufactured from a natural polymer biomaterial.
  • the augment is manufactured from a synthetic polymer biomaterial.
  • the augment is manufactured from a combination of a natural and synthetic polymer biomaterial.
  • a portion of the augment is manufactured from a resorbable biomaterial.
  • the entire augment is manufactured from a resorbable biomaterial.
  • the at least one fixation means is selected from the group consisting of pegs, pins, posts, buttons, keels, spikes and hooks.
  • the prosthesis system is a kit.
  • a method includes assessing a bone defect of a tibial bone; implanting an augment within the bone defect so as to create a substantially flush proximal surface, wherein the augment comprises a distal side that engages a surface of the bone defect, a proximal side, and an exterior profile defined by a posterior curvature, a lateral curvature, an anterior curvature, and a truncated aspect, wherein the distal side and the proximal side are separated by a thickness, wherein the distal side includes at least one fixation means sufficiently designed to facilitate implanting the augment to a surface of the bone associated with the void to repair the bone defect; adding bone graft material to the augment; positioning a tibial tray component on top of the proximal side of the augment; and fixing the tibial tray component to the augment.
  • the present invention provides a method, wherein the method restores bone support for an implant for joint arthroplasty, wherein the method comprises: a. assessing a defect of a bone, wherein the bone defect has a first void; b. preparing a first surface of the bone not associated with the first void; c. selecting a first individual augment from a kit, wherein the thickness of the first individual augment is sufficient to fill the first void; d. preparing a second surface of the bone associated with the first void and offset from the first surface by the thickness of the first individual augment; e. implanting the first individual augment within the second surface of the bone so the side configured to contact an implant of the first individual augment is substantially co-planar with the first surface of the bone; f. positioning an implant on top of the reconstructed flat surface created by the first surface of the bone and the side configured to contact an implant of the first individual augment; and g. fixing the implant to the bone and the side configured to contact an implant of the first individual augment.
  • bioactive bone graft material is added to the first individual augment.
  • the first individual augment is used in a joint arthroplasty selected from the group consisting of: total knee arthroplasty, total hip arthroplasty, and total shoulder arthroplasty; or wherein the first individual augment is used to restore bone stock in a bone defect selected from the group consisting of: a femoral bone defect, an acetabular bone defect, a humeral bone defect, a glenoid bone defect, and a periprosthetic bone defect.
  • the present invention provides a method, wherein the method restores bone support for an implant for joint arthroplasty, wherein the method comprises: a.
  • assessing a defect of a bone wherein the bone defect has a first and second void; b. selecting a first individual augment from a kit, wherein the thickness of the first individual augment is sufficient to fill the first void; c. preparing a first surface of the bone associated with the first void; d. selecting a second individual augment from the kit, wherein the thickness of the second individual augment is sufficient to fill the second void; e. preparing a second surface of the bone associated with the second void and offset from the first surface by the difference between the thickness of the first individual augment and the thickness of the second individual augment, f.
  • first individual augment within the first surface of the bone, and implanting the second individual augment within the second surface of the bone so the sides configured to contact an implant of the first and second individual augments are substantially co-planar; g. positioning an implant on top of the sides configured to contact an implant of the first and second individual augments; and h. fixing the implant to the sides configured to contact an implant of the first and second individual augments, wherein the exterior profiles of the first and second individual augments together substantially match an exterior profile of the implant.
  • bioactive bone graft material is added to the first individual augment, or the second individual augment, or the first and second individual augments.
  • the first and second individual augments are used in a joint arthroplasty selected from the group consisting of: total knee arthroplasty, total hip arthroplasty, and total shoulder arthroplasty; or wherein the first and second individual augments are used to restore bone stock in a bone defect selected from the group consisting of: a femoral bone defect, an acetabular bone defect, a humeral bone defect, a glenoid bone defect, and a periprosthetic bone defect.
  • the present invention provides a method, wherein the method restores bone support for an implant for joint arthroplasty, wherein the method comprises: a. assessing a defect of a bone, wherein the bone defect has a first void; b.
  • the thickness of the at least one first individual augment is sufficient to fill the first void and provide a surface for an implant; c. preparing a first surface of the bone associated with the first void; d. implanting the at least one first individual augment within the first surface of the bone; e. positioning the implant on top of the side configured to contact an implant of the at least one first individual augment; and f. fixing the implant to the side configured to contact an implant of the at least one first individual augment, wherein the exterior profile of the at least one first individual augment substantially match an exterior profile of the implant.
  • bioactive bone graft material is added to the at least one first individual augment.
  • the at least one first individual augment is used in a joint arthroplasty selected from the group consisting of: total knee arthroplasty, total hip arthroplasty, and total shoulder arthroplasty; or wherein the at least one first individual augment is used to restore bone stock in a bone defect selected from the group consisting of: a femoral bone defect, an acetabular bone defect, a humeral bone defect, a glenoid bone defect, and a periprosthetic bone defect.
  • the first individual augment is fixed to the bone by one of pegs, pins, posts, buttons, keels, spikes or hooks. In an embodiment, the at least one first individual augment is fixed to the bone by one of pegs, pins, posts, buttons, keels, spikes or hooks.
  • the second individual augment is fixed to the bone by one of pegs, pins, posts, buttons, keels, spikes or hooks.
  • the augment is manufactured from a metal biomaterial. In an embodiment, the augment is manufactured from a ceramic biomaterial. In an embodiment, the augment is manufactured from a composite biomaterial. In an embodiment, the augment is manufactured from a polymer biomaterial. In an embodiment, the augment is manufactured from a natural polymer biomaterial. In an embodiment, the augment is manufactured from a synthetic polymer biomaterial. In an embodiment, the augment is manufactured from a combination of a natural and synthetic polymer biomaterial. In an embodiment, a portion of the augment is manufactured from a resorbable biomaterial. In an embodiment, the entire augment is manufactured from a resorbable biomaterial.
  • the at least one fixation means is selected from the group consisting of pegs, pins, posts, buttons, keels, spikes and hooks.
  • the augments of the present invention combine the benefits of both shape matching technologies and new developments in materials and shape manufacturing to provide predictably resorbable biologically compatible materials for this intervention.
  • the augments of the present disclosure may be manufactured from a biological material, a biologically resorbable material, or a combination of biological and biologically resorbable materials, and are porous structures.
  • the augment is manufactured from a metal biomaterial.
  • the augment is manufactured from a ceramic biomaterial.
  • the augment is manufactured from a composite biomaterial.
  • the augment is manufactured from a polymer biomaterial.
  • the augment is manufactured from a natural polymer biomaterial. In an embodiment, the augment is manufactured from a synthetic polymer biomaterial. In an embodiment, the augment is manufactured from a combination of a natural and synthetic polymer biomaterial. In an embodiment, a portion of the augment is manufactured from a resorbable biomaterial. In an embodiment, the entire augment is manufactured from a resorbable biomaterial. In an embodiment, an augment of the present disclosure includes a three dimensional
  • 3D endoskeleton support for bioactive bone grafting material is sufficiently designed to directly attach to host bone (not the implant) and enables permanent restoration of bone support for metallic implant devices that are used to restore stability and function to the damaged joint (e.g., a tibial tray).
  • An augment of the present disclosure has a shape of which can be designed to fit a bone defect using anatomical information obtained from the patient.
  • an augment of the present invention has a wedge shape.
  • an augment of the present invention has a block shape.
  • An implanted augment of the present disclosure is sufficiently designed to restore and/or enhance local bone support for implants ("bone stock”) in situations of uncontained deficiencies (combined cortical and cancellous deficiencies that compromise implant support).
  • An implanted augment of the present disclosure is sufficiently designed to restore bone while providing support to the mechanical implant (e.g., a tibial tray), and offers the potential to improve patient bone support for future implants, even if the device implanted at the time of this augmentation requires revision. This concept seeks to develop the independence of these two events, so that restoration of bone support becomes one of the main goals of the operative intervention,not simply maintenance.
  • FIG. 1 is a schematic illustration of a tibia with a bone defect on the lateral side.
  • FIG. 2 shows a black-and-white line drawing of an embodiment of an augment of the present invention.
  • FIG. 3 shows an embodiment of a tibial tray component of a knee prosthesis.
  • FIG. 4 shows a black-and-white line drawing of an embodiment of an augment with spikes of the present invention.
  • FIG. 5 shows a black-and-white line drawing of an embodiment of an augment with pegs of the present invention.
  • FIG. 6 shows a black-and-white line drawing of an embodiment of an augment with keel of the present invention.
  • FIG. 7 is a schematic illustration showing the implanting of the tibial tray component of FIG. 3 into a reconstructed proximal tibia having an augment of the present invention.
  • FIG. 8 shows an embodiment of an augment with spikes of the present invention for use in a distal femoral augmentation.
  • FIG. 9 shows an embodiment of an augment with spikes of the present invention for use in a distal femoral augmentation.
  • FIG. 10 shows an embodiment of an augment with spikes of the present invention for use in a distal femoral augmentation.
  • the present invention relates to augments for bone deficiencies and a procedure for implanting these augments.
  • the augments of the present invention combine the benefits of both shape matching technologies and new developments in materials and shape manufacturing to provide predictably resorbable biologically compatible materials for this intervention.
  • the augments of the present disclosure may be manufactured from a biomaterial, a resorbable biomaterial or a combination of biomaterial and resorbable biomaterial.
  • the augment is manufactured from a metal biomaterial.
  • the augment is manufactured from a ceramic biomaterial.
  • the augment is manufactured from a composite biomaterial.
  • the augment is manufactured from a polymer biomaterial.
  • the augment is manufactured from a natural polymer biomaterial.
  • the augment is manufactured from a synthetic polymer biomaterial. In an embodiment, the augment is manufactured from a combination of a natural and synthetic polymer biomaterial. In an embodiment, a portion of the augment is manufactured from a resorbable biomaterial. In an embodiment, the entire augment is manufactured from a resorbable biomaterial.
  • an augment of the present disclosure includes a three dimensional (3D) endoskeleton support for bioactive bone grafting material and is sufficiently designed to directly attach to host bone (not the implant) and enables permanent restoration of bone support for metallic implant devices that are used to restore stability and function to the damaged joint (e.g., a tibial tray).
  • An augment of the present disclosure has a shape of which can be designed to fit a bone defect using anatomical information obtained from the patient.
  • an augment of the present invention includes a three dimensional (3D) endoskeleton support for bioactive bone grafting and is manufactured from a biomaterial, a resorbable biomaterial or a combination of biomaterial and resorbable biomaterial.
  • the biomaterial of the augment displays both mechanical resilience and provides an osteoconductive surface.
  • the augments of the present invention are first attached to the host bone. The addition of the augment to the bone is intended to restore the native shape of the bone. Next, the surgeon will position the implant (e.g., a tibial tray) on top of the augment and contact the two. In the event of a future revision, it is expected the osteointegrated augment stays attached to the bone, resulting in no additional patient bone loss at the level of the augment.
  • An augment of the present invention is available in a variety of sizes and shapes to accommodate defects of various sizes. Both the choice of the biomaterial and the design of the augment are defined in order to sustain the physiological loading pattern associated with the considered joint.
  • An augment of the present invention is sufficiently designed to function as a load bearing implant. In an embodiment, an augment of the present invention has high tensile, high fatigue and high yield strengths. In an embodiment, an augment of the present invention has low reactivity.
  • biomaterial refers to a synthetic or natural material appropriate for long term use in the body as a medical implant.
  • materials that are synthetic include, but are not limited to, polymers (e.g., PEEK or polyethylene), ceramics or bioglass materials (e.g., calcium phosphates or oxides, or carbon or graphite based materials such as pyrolitic carbon).
  • polymers such as polypeptides, including collagen materials derived from humans, animals, or recombinant organisms, which may be modified to reduce or eliminate degradation in the body, polysaccharides such as cellulosic materials, starches, or chitin, or materials consisting of or derived from the bone of human or animal origin or metals.
  • resorbable biomaterial refers to the subset of "biomaterial” that can be a resorbable material, meaning a material that is designed to disintegrate in the body over time.
  • resorbable materials that are synthetic include polymers such as the polyesters PLGA and PLLA, polyanhydrides, polyorthoesters, or polyamides, or certain ceramic or oxide based materials such as calcium sulfates or bioglasses.
  • Such materials of natural origin include polymers such as polypeptides, including collagen materials derived from humans, animals, or recombinant organisms, polysaccharides, such as alginates, hyaluronan, or chitosan, including polysaccharides that are modified to enhance resorbability by processes such as oxidation.
  • polymers such as polypeptides, including collagen materials derived from humans, animals, or recombinant organisms, polysaccharides, such as alginates, hyaluronan, or chitosan, including polysaccharides that are modified to enhance resorbability by processes such as oxidation.
  • bioactive bone graft material refers to autologous material (e.g., bone harvested from the patient's own body, often from the iliac crest), allograft material (e.g., cadaveric bone usually obtained from a bone bank), or synthetic material (e.g., often made of hydroxyapatite or other naturally occurring and biocompatible substances) with similar mechanical properties to bone.
  • autologous material e.g., bone harvested from the patient's own body, often from the iliac crest
  • allograft material e.g., cadaveric bone usually obtained from a bone bank
  • synthetic material e.g., often made of hydroxyapatite or other naturally occurring and biocompatible substances
  • the term "thickness" refers to the dimension between the distal surface and the proximal surface of an augment of the present invention.
  • An augment can be of varying thickness in the range of approximately 1 mm to 30 mm, and preferably of 5 mm to about 11 mm. Desired thickness can be achieved by selecting or shaping a single augment to desired thickness, or by stacking multiple augments.
  • void refers to a volume of bone loss or a bone defect in cancellous bone, cortical bone, or both cancellous and cortical bone.
  • an augment of the present invention acts as a 3D endoskeleton support for bioactive bone graft material and includes interconnected "macropores", typically of 100 ⁇ to about 3 mm diameter.
  • the macropores range from about 1 mm-3mm diameter. In an embodiment, the macropores range from about 100-1000 ⁇ diameter. In an embodiment, the macropores range from about 150-900 ⁇ diameter. In an embodiment, the macropores range from about 200-800 ⁇ diameter. In an embodiment, the macropores range from about 300-700 ⁇ diameter. These macropores provide a framework for the host bone to regenerate while reducing healing time. The macropores allow bone tissue to grow into the augment to yield cell/augment integration.
  • biomaterials used for the augments should be microporous with a pore diameter of 1-10 ⁇ .
  • the micropores range from about 2-9 ⁇ diameter.
  • the micropores range from about 3-8 ⁇ diameter.
  • the micropores range from about 4-7 ⁇ diameter.
  • Such micropores have been found to improve the ability of osteoblasts and other cells from the host to bind to the biomaterial of the augment and to allow access of the cells to dissolve the sintered connections between the individual particles.
  • Table I Comparison between conventional technique for a revision total knee replacement and technique of the present invention when applied to bone deficiency of the proximal tibia. Text in italics is intended to emphasize the difference between the two techniques.
  • a bone defect where the proximal tibia (10) has a defect on its lateral aspect (11) (see FIG. 1).
  • the initial steps of the preparation are going to be as described above in steps 1 and 2, where the surgeon prepares the proximal tibia using a resection guide.
  • the surgeon uses an augment of the present invention (100a, 100b, 100c or lOOd) (see FIGS. 2, 4, 5 and 6) with overall dimensions more or less matching those of a standard conventional metal augment (see right side of Table 1).
  • the exterior profile 100a, 100b, 100c or lOOd
  • (110) of the augment (100a, 100b, 100c or lOOd) is dimensionally equivalent to the outside profile (51) of a tibial tray component (50) (see FIG. 3) except for one aspect that is truncated
  • the truncated aspect (111) is designed so the augment covers one half or one third of the tibial tray component (50) distal surface (52).
  • the augment (100a, 100b, 100c or lOOd) features two opposite surfaces: a distal surface (120) intended to contact the proximal tibia at the surface of the defect (11) and a proximal surface (130) intended to contact the distal aspect (52) of the tibial tray component (50); where both surfaces are separated by a dimension (A; where usually A ranges from 5 mm to 20 mm) consistent with the thickness (A) of the void to be addressed in repairing the defect.
  • the exterior profile (110) of the augment (100a, 100b, 100c or lOOd) has a posterior curvature, a lateral curvature and an anterior curvature.
  • the distal surface (120) of the augment (100a, 100b, 100c or lOOd) features a network of channels or openings (121) intended to receive bioactive bone graft material at the time of implantation.
  • the distal surface may feature spikes (122) (see FIG. 4), pegs (123) (see FIG. 5), or a keel (124) (see FIG. 6) to facilitate anchoring with the receiving bone at the surface associated with the void (11) by improving the stability of the augment (100a, 100b, 100c or lOOd) relative the bone (10) after implantation.
  • the spikes, pegs and keel can be self- locking and provide resistance to anterior and posterior translation, liftoff, and subsidence.
  • the augment (100a, 100b, 100c or lOOd) can include a countersink (140) intended to receive a fastener (e.g., locking screw or other type of device to allow proper anchorage) to lock the augment (100a, 100b, 100c or lOOd) relative to the bone (10).
  • a fastener e.g., locking screw or other type of device to allow proper anchorage
  • the surgeon introduces the bioactive bone graft (not represented) into the network of channels or openings (121) of the augment (100a, 100b, 100c or lOOd) up to saturation. Then the surgeon positions and impacts the augment (100a, 100b, 100c or lOOd) into the bone defect (11). It is understood that depending on the size of the spikes (122) (see FIG. 4), pegs (123) (see FIG. 5), or keel (124) (see FIG. 6), pre-drilling or tamping may be needed to facilitate impaction.
  • the augment (100a, 100b, 100c or lOOd) is seeded with living cells capable of regenerating bone. In an embodiment, the augment (100a, 100b, 100c or lOOd) is seeded with living cells capable of regenerating bone in an amount sufficient to regenerate bone.
  • the augment (100a, 100b, 100c or lOOd) With the augment (100a, 100b, 100c or lOOd) in place, its proximal surface (130) should be substantially flush with the healthier, more proximal surface of the proximal tibia (12). It is understood at this point the void associated with the bone defect (11) has been filled by the augment (100a, 100b, 100c or lOOd).
  • the surgeon can implant the tibial tray component (50) onto the reconstructed and now substantially co-planar surface (12 and 130) (see FIG. 7) using conventional PMMA bone cement or another type of material intended to fix two materials together (not represented).
  • the other components of the knee prosthesis can then be implanted as known in the art.
  • a single augment is used to restore bone support in a single void to repair a defect in a bone.
  • at least one augment is used to restore bone support in a void to repair a single defect in a bone.
  • at least one augment is used to restore bone support in at least one void to repair a defect in a bone.
  • the present invention provides a method, wherein the method restores bone support for an implant for joint arthroplasty, wherein the method comprises: a. assessing a defect of a bone, wherein the bone defect has a first void; b. preparing a first surface of the bone not associated with the first void; c. selecting a first individual augment from a kit, wherein the thickness of the first individual augment is sufficient to fill the first void; d. preparing a second surface of the bone associated with the first void and offset from the first surface by the thickness of the first individual augment; e.
  • bioactive bone graft material is added to the first individual augment.
  • the first individual augment is used in a joint arthroplasty selected from the group consisting of: total knee arthroplasty, total hip arthroplasty, and total shoulder arthroplasty; or wherein the first individual augment is used to restore bone stock in a bone defect selected from the group consisting of: a femoral bone defect, an acetabular bone defect, a humeral bone defect, a glenoid bone defect, and a periprosthetic bone defect.
  • the present invention provides a method, wherein the method restores bone support for an implant for joint arthroplasty, wherein the method comprises: a. assessing a defect of a bone, wherein the bone defect has a first and second void; b. selecting a first individual augment from a kit, wherein the thickness of the first individual augment is sufficient to fill the first void; c. preparing a first surface of the bone associated with the first void; d. selecting a second individual augment from the kit, wherein the thickness of the second individual augment is sufficient to fill the second void; e.
  • preparing a second surface of the bone associated with the second void and offset from the first surface by the difference between the thickness of the first individual augment and the thickness of the second individual augment f. implanting the first individual augment within the first surface of the bone, and implanting the second individual augment within the second surface of the bone so the sides configured to contact an implant of the first and second individual augments are substantially co-planar; g. positioning an implant on top of the sides configured to contact an implant of the first and second individual augments; and h. fixing the implant to the sides configured to contact an implant of the first and second individual augments, wherein the exterior profiles of the first and second individual augments together substantially match an exterior profile of the implant.
  • bioactive bone graft material is added to the first individual augment, or the second individual augment, or the first and second individual augments.
  • the first and second individual augments are used in a joint arthroplasty selected from the group consisting of: total knee arthroplasty, total hip arthroplasty, and total shoulder arthroplasty; or wherein the first and second individual augments are used to restore bone stock in a bone defect selected from the group consisting of: a femoral bone defect, an acetabular bone defect, a humeral bone defect, a glenoid bone defect, and a periprosthetic bone defect.
  • the present invention provides a method, wherein the method restores bone support for an implant for joint arthroplasty, wherein the method comprises: a. assessing a defect of a bone, wherein the bone defect has a first void; b. selecting at least one first individual augment from a kit, wherein the thickness of the at least one first individual augment is sufficient to fill the first void and provide a surface for an implant; c. preparing a first surface of the bone associated with the first void; d. implanting the at least one first individual augment within the first surface of the bone; e. positioning the implant on top of the side configured to contact an implant of the at least one first individual augment; and f. fixing the implant to the side configured to contact an implant of the at least one first individual augment, wherein the exterior profile of the at least one first individual augment substantially match an exterior profile of the implant.
  • bioactive bone graft material is added to the at least one first individual augment.
  • the at least one first individual augment is used in a joint arthroplasty selected from the group consisting of: total knee arthroplasty, total hip arthroplasty, and total shoulder arthroplasty; or wherein the at least one first individual augment is used to restore bone stock in a bone defect selected from the group consisting of: a femoral bone defect, an acetabular bone defect, a humeral bone defect, a glenoid bone defect, and a periprosthetic bone defect.
  • the first individual augment is fixed to the bone by one of pegs, pins, posts, buttons, keels, spikes or hooks.
  • the at least one first individual augment is fixed to the bone by one of pegs, pins, posts, buttons, keels, spikes or hooks.
  • the second individual augment is fixed to the bone by one of pegs, pins, posts, buttons, keels, spikes or hooks.
  • an augment of the present invention can be sufficiently designed as a medial augment or a full medial/lateral augment (e.g., similar in size and shape to a tibial tray component), which effectively has a posterior surface sized to match a tibial tray.
  • An augment of the present invention can be placed into contact or connection with both an implant and a bone surface prepared to receive an implant.
  • Contact or “connection” according to the present invention is either direct physical interface with an implant and/or a bone surface, or, optionally, indirect interface with an implant and/or bone surface, in which an intermediary substance, such as cancellous bone paste or bone cement, is interposed between the augment and the implant and/or bone surface.
  • Implanting an augment of the present invention can be completed using the same basic instrumentation (e.g., resection guide) as the conventional technique. Transitioning from using a conventional metallic augment that is biocompatible but has no biological activity to using an augment of the present invention will provide biological restoration of missing bone, and can advantageously provide an improved bone environment should the joint require additional revision.
  • the augment 100a, 100b, 100c or lOOd
  • the surgeon follows the same steps as described above with the exception the surgeon will shape the contour of the augment (100a, 100b, 100c or lOOd) to match the defect.
  • the augment (100a, 100b, 100c or lOOd) can be semi- contained into a housing made from a different material.
  • the surface of the augment (100a, 100b, 100c or lOOd) in contact with the receiving bone will not be fully covered by the housing, enabling osteointegration to take place.
  • An augment of the present invention can be manufactured by an additive technology such as three dimensional printing (3DP) or stereolithography using, for example, Calcium Hydroxyapatite-Tricalcium Phosphate (HA-TCP) powder.
  • additive technology such as three dimensional printing (3DP) or stereolithography using, for example, Calcium Hydroxyapatite-Tricalcium Phosphate (HA-TCP) powder.
  • HA-TCP Calcium Hydroxyapatite-Tricalcium Phosphate
  • the porous structure may be produced by Laser Engineered Net Shaping (LENS®), a process where tiny particles are blown into the path of a laser and melted. The material cools and hardens as soon as it is out of the laser beam, and custom parts can be quickly built up layer by layer. The process is so precise that augments can be used straight off the printer without the polishing or finishing needed in traditional manufacturing.
  • LENS® process allows augments to be manufactured with microscopic holes for bone to grow into and attach.
  • the augments created from LENS® can integrate into the body more effectively, encouraging bone regrowth that ultimately result in a stronger, longer lasting augment.
  • a CT scan or MRI can be used to make a 3-D model of the bone defect.
  • the augment includes a three dimensional endoskeleton support having interconnected macropores providing a framework for host bone to grow into the augment.
  • the augment has a proximal side (sufficiently designed to contact a receiving bone), a distal side (sufficiently designed to contact an implant) and an exterior profile, wherein the proximal side and the distal side are separated by a thickness, wherein the proximal side includes at least one fixation means sufficiently designed to facilitate anchoring of the augment to the receiving bone.
  • the augments include a proximal side (sufficiently designed to contact a receiving bone) with a 3D pattern, a solid distal side (sufficiently designed to contact an implant), and an exterior profile, wherein the proximal side and the distal side are separated by a thickness, wherein the augment includes at least one hole for fixing the augment to the receiving bone.
  • the only difference between FIG. 9 and 10 relates to the 3D pattern of the proximal side.
  • the outside shell aspect is the same for both types.
  • the proximal side is sufficiently designed to be filled with bioactive bone graft.
  • pre-made augments are provided with a bioactive bone graft component overlying an endoskeleton structure.
  • a biologic endoskeleton (as described above) of fixed shape is manufactured, readily available, and provides both structure and bioactive bone graft as a single unit, requiring only attachment to bone.
  • the mild modifications to the implanted devices discussed above might be used in conjunction with the implanted metallic and endoskeleton devices to protect the graft and load it properly, while incorporation and remodeling occur.
  • This might be in the form of customizable augments (based upon CT or MRI 3-D reconstructions) or from prefabricated shapes- such as cones and sleeves.
  • an augment of the present invention can be used during a total knee arthroplasty (TKA).
  • TKA total knee arthroplasty
  • an augment of the present invention can be used to restore patient bone stock in cases of a tibia bone defect.
  • an augment of the present invention can be used to restore patient bone stock in cases of a femoral bone defect.
  • an augment of the present invention can be used during total hip arthroplasty (THA).
  • TSA total hip arthroplasty
  • an augment of the present invention can be used to restore patient bone stock in cases of an acetabular bone defect.
  • an augment of the present invention can be used during total shoulder arthroplasty (TSA).
  • an augment of the present invention can be used to restore patient bone stock in cases of a humeral bone defect. In an embodiment, an augment of the present invention can be used to restore patient bone stock in cases of a glenoid bone defect. In an embodiment, an augment of the present invention can be used to restore patient bone stock in cases of a periprosthetic bone defect. This benefit is achieved by primarily attaching/securing a augment to the bone prior to placement of the implant (rather than primarily attaching/securing a metal augment to the implant, as with the current method).
  • an augment of the present invention includes a three dimensional endoskeleton support having interconnected macropores, the macropores providing a framework for host bone to grow into the augment, wherein the support is manufactured from a microporous biomaterial, wherein the support has a distal surface, a proximal surface and an exterior profile defined by a posterior curvature, a lateral curvature, an anterior curvature, and a truncated aspect, wherein the distal surface and the proximal surface are separated by a thickness, wherein the distal surface includes at least one fixation means sufficiently designed to facilitate anchoring of the augment to a receiving bone, and wherein the proximal surface is sufficiently designed to engage a component of an orthopaedic implant.
  • a prosthesis system includes a joint prosthesis component; and an augment comprising a distal surface, a proximal surface, and thickness therebetween, at least one of which mimics an exterior profile of the joint prosthesis component, wherein the distal surface includes at least one fixation means sufficiently designed to facilitate anchoring of the augment to a receiving bone, and wherein the proximal surface is sufficiently designed to engage a surface of the joint prosthesis component.
  • the system further includes bioactive bone graft material.
  • a knee prosthesis system includes a tibial tray component having an inferior surface, a superior surface, and an exterior profile; and an augment comprising a distal surface, a proximal surface and an exterior profile defined by a posterior curvature, a lateral curvature, an anterior curvature, and a truncated aspect, at least one of which mimics the exterior profile of the tibial tray component, wherein the distal surface and the proximal surface are separated by a thickness, wherein the distal surface includes at least one fixation means sufficiently designed to facilitate anchoring of the augment to a receiving bone, and wherein the proximal surface is sufficiently designed to engage the inferior surface of the tibial tray component.
  • the system further includes bioactive bone graft material.
  • a method of the present invention includes assessing a bone defect of a tibial bone; implanting an augment within the bone defect so as to create a substantially flush proximal surface, wherein the augment comprises a distal surface, a proximal surface and an exterior profile defined by a posterior curvature, a lateral curvature, an anterior curvature, and a truncated aspect, wherein the distal surface and the proximal surface are separated by a thickness, wherein the distal surface includes at least one fixation means sufficiently designed to facilitate anchoring of the augment into a void created by the bone defect; adding bioactive bone graft material to the augment; positioning a tibial tray component on top of the proximal surface of the augment; and fixing the tibial tray component to the augment.

Landscapes

  • Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Prostheses (AREA)

Abstract

Dans un mode de réalisation, la présente invention concerne une augmentation comprenant : a) un côté conçu pour entrer en contact avec et se fixer à un os récepteur; b) un côté conçu pour entrer en contact avec un implant; et c) un profil extérieur, cette augmentation étant caractérisée en ce que le côté conçu pour entrer en contact avec un os récepteur et le côté conçu pour entrer en contact avec un implant sont séparés par une certaine épaisseur, et en ce qu'elle est conçue pour s'ancrer sur l'os récepteur.
PCT/US2016/012491 2015-01-07 2016-01-07 Augmentations pour déficits osseux WO2016112191A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/554,189 US20180049878A1 (en) 2015-01-07 2016-01-07 Augments for bone deficiencies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562100626P 2015-01-07 2015-01-07
US62/100,626 2015-01-07

Publications (1)

Publication Number Publication Date
WO2016112191A1 true WO2016112191A1 (fr) 2016-07-14

Family

ID=56356428

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/012491 WO2016112191A1 (fr) 2015-01-07 2016-01-07 Augmentations pour déficits osseux

Country Status (2)

Country Link
US (1) US20180049878A1 (fr)
WO (1) WO2016112191A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107260369A (zh) * 2017-06-15 2017-10-20 西安交通大学 一种用于全膝关节置换术中骨缺损的个性化生物型垫块
IT201800009555A1 (it) * 2018-10-18 2020-04-18 Tecres Spa Dispositivo intermedio o inserto sotto-tibiale, componente protesico dotato di tale dispositivo intermedio e metodo per il loro assemblaggio

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104887355B (zh) * 2015-05-08 2017-05-03 江苏奥康尼医疗科技发展有限公司 一种人工膝关节胫骨托
EP3600469B1 (fr) * 2017-03-30 2023-06-14 Marquette University Prothèse synthétique pour utilisation en chirurgie d'ostéo-odonto-kératoprothèse (ookp)
RU191495U1 (ru) * 2018-08-16 2019-08-07 федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный медицинский университет имени В.И. Разумовского" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Саратовский ГМУ им. В.И. Разумовского Минздрава России) Аугмент для пластики краевых костных дефектов при эндопротезировании коленного сустава
RU191493U1 (ru) * 2018-08-16 2019-08-07 федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный медицинский университет имени В.И. Разумовского" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Саратовский ГМУ им. В.И. Разумовского Минздрава России) Аугмент для замещения краевых костных дефектов коленного сустава
RU191504U1 (ru) * 2018-08-16 2019-08-08 федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный медицинский университет имени В.И. Разумовского" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Саратовский ГМУ им. В.И. Разумовского Минздрава России) Аугмент под феморальный компонент эндопротеза коленного сустава
EP3666228A1 (fr) * 2018-12-14 2020-06-17 Howmedica Osteonics Corp. Fabrication augmentée, juste à temps, d'implant spécifique à un patient
RU192080U1 (ru) * 2019-04-11 2019-09-03 Общество с ограниченной ответственностью "Эндокарбон" Клин эндопротеза коленного сустава
US11998450B2 (en) * 2020-04-01 2024-06-04 Arthrex, Inc. Systems and methods of forming orthopaedic implants including printed augments

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040162619A1 (en) * 2001-08-27 2004-08-19 Zimmer Technology, Inc. Tibial augments for use with knee joint prostheses, method of implanting the tibial augment, and associated tools
US20060100714A1 (en) * 2003-04-02 2006-05-11 Ortho Development Corporation Tibial augment connector
US20100004702A1 (en) * 2005-11-07 2010-01-07 Howmedica Osteonics Corp. Tibial Augmentation Guide
US20110202141A1 (en) * 2010-02-18 2011-08-18 Biomet Manufacturing Corp. Method and apparatus for augmenting bone defects
US20120185053A1 (en) * 2010-11-23 2012-07-19 Richard Berger Spacer Apparatus and Method for Achieving Improved Fit and Balance in Knee Joints
US20120215311A1 (en) * 2011-02-22 2012-08-23 Todd Parry Arthroplasty shim
US20140172113A1 (en) * 2011-12-07 2014-06-19 Smith & Nephew, Inc. Orthopedic augments having recessed pockets
US20140277529A1 (en) * 2013-03-15 2014-09-18 Smed-Ta/Td, Llc Removable augment for medical implant
US20140277539A1 (en) * 2013-03-14 2014-09-18 Michael A. Cook Orthopaedic tibial prosthesis having tibial augments

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040162619A1 (en) * 2001-08-27 2004-08-19 Zimmer Technology, Inc. Tibial augments for use with knee joint prostheses, method of implanting the tibial augment, and associated tools
US20060100714A1 (en) * 2003-04-02 2006-05-11 Ortho Development Corporation Tibial augment connector
US20100004702A1 (en) * 2005-11-07 2010-01-07 Howmedica Osteonics Corp. Tibial Augmentation Guide
US20110202141A1 (en) * 2010-02-18 2011-08-18 Biomet Manufacturing Corp. Method and apparatus for augmenting bone defects
US20120185053A1 (en) * 2010-11-23 2012-07-19 Richard Berger Spacer Apparatus and Method for Achieving Improved Fit and Balance in Knee Joints
US20120215311A1 (en) * 2011-02-22 2012-08-23 Todd Parry Arthroplasty shim
US20140172113A1 (en) * 2011-12-07 2014-06-19 Smith & Nephew, Inc. Orthopedic augments having recessed pockets
US20140277539A1 (en) * 2013-03-14 2014-09-18 Michael A. Cook Orthopaedic tibial prosthesis having tibial augments
US20140277529A1 (en) * 2013-03-15 2014-09-18 Smed-Ta/Td, Llc Removable augment for medical implant

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107260369A (zh) * 2017-06-15 2017-10-20 西安交通大学 一种用于全膝关节置换术中骨缺损的个性化生物型垫块
IT201800009555A1 (it) * 2018-10-18 2020-04-18 Tecres Spa Dispositivo intermedio o inserto sotto-tibiale, componente protesico dotato di tale dispositivo intermedio e metodo per il loro assemblaggio
WO2020079516A1 (fr) * 2018-10-18 2020-04-23 Tecres S.P.A. Dispositif intermédiaire ou insert sous-tibial, composant prothétique pourvu d'un tel dispositif intermédiaire et procédé d'assemblage

Also Published As

Publication number Publication date
US20180049878A1 (en) 2018-02-22

Similar Documents

Publication Publication Date Title
US20180049878A1 (en) Augments for bone deficiencies
US20200015973A1 (en) Tissue integration design for seamless implant fixation
FRAKENBURG et al. Biomechanical and histological evaluation of a calcium phosphate cement
EP2338530B1 (fr) Bouchon métallique/polymère hybride pour traiter les défauts chondraux
US8187336B2 (en) Device and method for reconstruction of osseous skeletal defects
US20050010304A1 (en) Device and method for reconstruction of osseous skeletal defects
US20080154379A1 (en) Interbody fusion hybrid graft
Palmquist et al. Complex geometry and integrated macro-porosity: Clinical applications of electron beam melting to fabricate bespoke bone-anchored implants
Patil et al. Porous tantalum in hip and knee reconstructive surgery
US20040078078A1 (en) Cortical and cancellous allograft cervical fusion block
US20110257753A1 (en) Implant having a convex surface surrounding a concave articular surface
WO2012003036A2 (fr) Implant orthopédique monolithique présentant une surface articulaire finie
KR20120112670A (ko) 보철물
US11918707B2 (en) Implant, preferably for the treatment of an acetabular defect
EP3071153A1 (fr) Système d'augmentation pour implant
AU2011271681A1 (en) Convex concave implant
US20070173949A1 (en) Bonding system for orthopedic implants
George et al. 1Post Graduate and Research Department of Chemistry, Maharaja’s College, Ernakulam, Kerala, India, 2Department of Chemistry, Union Christian College, Aluva, Kerala, India
Abbah et al. Fusion Performance of a Bioresorbable Cage Used In Porcine Model of Anterior Lumbar Interbody Fusion
Bafan et al. Bioceramics: The Future of Joint Healing

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16735412

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16735412

Country of ref document: EP

Kind code of ref document: A1